EVANSVILLE, Indiana , Oct. 8, 2024 /CNW/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, and Old National Bank (NASDAQ: ONB), the sixth largest commercial bank headquartered in the Midwest, recently entered into a strategic expansion of their four-year collaboration. This deepening of a highly successful relationship enables Old National to leverage Infosys services, solutions and platforms for operations transformation and process digitization powered by automation and GenAI, and transformation of key business areas.

Since 2020, Infosys has helped Old National modernize its digital landscape using a highly efficient, self-funding model. The resulting uplift in stability, resiliency and improved client experience has served to accelerate and sustain Old National’s growth.

Jim Ryan, Chairman & CEO, Old National Bank, said, “At Old National, we are committed to creating exceptional client and team member experiences. Infosys is expertly guiding us through business process enhancements, with a strong emphasis on efficiency and value generation. We greatly appreciate Infosys’ commitment to our growth and success.”

Dennis Gada, EVP and Global Head of Banking and Financial Services, said, “Old National Bank and Infosys share a strong cultural and strategic alignment in developing, managing, and enhancing enterprise-scale solutions to transform the bank’s operations and support growth. We are excited to further accelerate Old National Bank’s business process and customer care transformation using Infosys Topaz. Our extensive experience in domain, technology, and operations, specifically for mid-sized and regional banks, will continue to bring deep growth and efficiency advantage for this segment.”

About Old National

Old National Bancorp (NASDAQ: ONB) is the holding company of Old National Bank. As the sixth largest commercial bank headquartered in the Midwest, Old National proudly serves clients primarily in the Midwest and Southeast. With approximately $53 billion of assets and $30 billion of assets under management, Old National ranks among the top 30 banking companies headquartered in the United States. Tracing our roots to 1834, Old National focuses on building long-term, highly valued partnerships with clients while also strengthening and supporting the communities we serve. In addition to providing extensive services in consumer and commercial banking, Old National offers comprehensive wealth management and capital markets services. For more information and financial data, please visit Investor Relations at oldnational.com. In 2024, Points of Light named Old National one of “The Civic 50” — an honor reserved for the 50 most community-minded companies in the United States.

About Infosys

Infosys is a global leader in next-generation digital services and consulting. Over 300,000 of our people work to amplify human potential and create the next opportunity for people, businesses and communities. We enable clients in more than 56 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as Generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2024. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

Logo: https://mma.prnewswire.com/media/633365/4364085/Infosys_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/infosys-collaboration-with-old-national-is-accelerating-the-banks-operational-and-technological-transformation-302270055.html

SOURCE Infosys

Axtria showcases its collaboration with leading pharma companies on AI-driven insights, field force optimization, and data strategies.

CHICAGO, Oct. 8, 2024 /PRNewswire/ — Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, shared its leadership in driving innovative solutions for life sciences companies at the PMSA 2024 Fall Symposium. The two-day summit, held in Chicago on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare. Axtria earned several awards at the conference for thought leadership presentations, and once again participated as a gold sponsor, reiterating its commitment to exchanging knowledge to enhance the impact of AI in the pharmaceutical industry.

“At Axtria, we believe that AI is not just a tool, but a transformative force that can reshape the pharmaceutical landscape,” said Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria. “Our participation in the PMSA 2024 Fall Symposium reflects our commitment to partnering with industry leaders to harness AI-driven insights and solutions that enhance decision-making, optimize field operations, and ultimately improve patient outcomes.”

Axtria’s experts, alongside client partners, led insightful presentations and discussions, showcasing advanced AI-driven solutions and strategies tailored for the pharmaceutical industry:

Axtria, alongside Gilead Sciences, presented a case study on Nuances of Leveraging Generative AI for Structured Data Processing and Insights. This highlighted the importance of empowering non-technical users to access insights via natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.

Axtria teamed up with Astellas Pharma to present a case study on AI-Enabled Action Alerts to Enhance Field Effectiveness. This collaboration demonstrated how AI-powered recommendations are transforming field operations by providing reps with actionable insights to optimize their engagements, increase prescription (Rx) uptake, and enhance overall brand performance. This presentation showed how Astellas and Axtria worked together to leverage data, convert it to useful rep suggestions, and ultimately improve brand performance through better field execution.

Together with Bayer, Axtria discussed Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations. This session explored Bayer’s AI-driven transformation of field force operations across design, planning, execution, and talent management, showcasing the tangible business impact of AI.

Axtria led a session on Enabling EDA Automation for Commercial Analytics using LLM. This workshop demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy. Axtria shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.

About Axtria’s Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world’s leading providers of cloud-based pharmaceutical management software, Axtria has been powering the digital transformation of life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.

About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

Logo – https://mma.prnewswire.com/media/2256316/Axtria_transparent_bg_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/axtria-showcases-ai-powered-innovations-at–pmsa-2024-fall-symposium-302269330.html

Platform Aims to Provide Capital, Strategic Support, and Resources to Propel Minority, Veteran, and Women-Led Startups

RALEIGH, N.C., Oct. 8, 2024 /PRNewswire-PRWeb/ — Fuze Fund is thrilled to announce the launch of Fuze Venture Growth Fund I, LP, a $30 million Reg-D 506(c) fund designed to bridge the equity gap in venture capital. Recently approved by the U.S. Securities and Exchange Commission (SEC), the fund aims to raise and deploy capital to support minority, women, and veteran founders. Now in its subscription phase, Fuze Fund is inviting accredited investors to become part of this journey—not just by providing capital, but by contributing to an ecosystem that nurtures founders with resources, mentorship, and the strategic support they need for long-term success.

“At Fuze Fund, we’re driven by the belief that innovation knows no boundaries. Yet, we’ve seen far too many talented founders from underrepresented communities being sidelined due to a lack of access to funding,” says Dr. T.J. Breeden, Managing Partner of Fuze Fund. “Our goal is simple: to ignite potential. We’re not just backing startups—we’re investing in people, in communities, and in the next generation of game-changing ideas.”

HOW IT STARTED:

Dr. Breeden’s inspiration for launching Fuze Fund was deeply rooted in his experience leading Emerging Entrepreneurs, Inc., a non-profit dedicated to providing startup training to untapped communities, particularly veterans and minority populations. “While leading Emerging Entrepreneurs, Inc., I saw firsthand how difficult it was for underrepresented founders to access the funding and support they needed to succeed,” Dr. Breeden explains. “It became clear to me that the Venture Capital space was not fully supporting these communities.” This realization grew into a larger vision during Dr. Breeden’s MBA studies at Syracuse University, where a group capstone project merged with research from the university’s Institute for Veterans and Military Families. “The concept of launching a fund that focused on empowering veteran, minority, and women-led projects took shape during my time at Syracuse,” he continues. “Though a few years passed and I went on to complete my doctoral studies at the University of Illinois Urbana-Champaign, the hope of one day launching a fund never left me. Less than 4 months after defending my dissertation, in the fall of 2021 and in the midst of the pandemic, Fuze Fund and its flagship venture fund were formed.”

The statistics are telling: in 2022, minority founders received only 1.1% of venture capital funding, despite their growing presence in the startup ecosystem. Investment declined to less than 1% in 2023. Fuze Fund is committed to changing this by channeling institutional capital into promising early-stage ventures across industries like technology, education, and financial services. But Fuze Fund’s commitment goes beyond just financial investment; it provides founders with a strong network of partnerships, including institutions, non-profits, and industry leaders—all working together to fuel sustainable growth. “We understand that capital alone doesn’t drive success—it’s about the support and resources that surround it,” Dr. Breeden continues. “That’s why we’re building an ecosystem that connects founders with the right people and tools, helping them navigate the challenges of growth and scale with confidence.”

While the firm’s flagship fund, Fuze Venture Growth Fund I, will focus on ventures led by diverse leadership teams with innovative business models, particularly in areas like EdTech, AI & Robotics, Consumer Packaged Goods, Fintech, and Digital Services, Fuze Fund is also exploring adjacent industries that leverage technology to drive innovation and create transformative change.

FUZE FUND EXPANDS SUPPORT THROUGH CONSULTING PLATFORM:

In addition to its venture capital initiatives, Fuze Fund offers a robust range of management consulting services tailored to the needs of institutions, startup communities, and founders. From fund structuring and compliance to capital raising and ecosystem development, the Fuze Fund consulting team provides hands-on expertise to guide emerging ventures. These services ensure that founders and institutions have a clear path to success in an increasingly competitive market. “We’re eager to connect with firms, institutions, and agencies who believe in the power of collective investment, knowledge sharing, and strategic collaboration,” says Breeden. “Impact isn’t restricted to wiring funds. Rather, creating real, lasting impact is a holistic endeavor that requires a range of inputs, from raising capital to building connections to leveraging data and insights to make more informed business decisions.”

ABOUT DR. T.J. BREEDEN, FOUNDER & MANAGING PARTNER:

Dr. T.J. Breeden is a nationally recognized entrepreneur and advocate for transitioning service members, underserved founders, and youth. Honored by President Obama as a “Champion of Change” as part of the former administration’s “Winning the Future” initiative, T.J. has been celebrated for his leadership in advancing economic opportunities for minority and veteran founders. He was also named the “Veterans Entrepreneurship Advocate of the Year” by the U.S. Small Business Administration, received BlackEnterprise Magazine’s “Modern Man of Distinction” award, and Radio One’s “Cathy Hughes Business Community Service” award. T.J. also serves in a Director’s role at a leading philanthropy-serving organization whose mission is to advance equitable philanthropic investment in Black communities.

Recently, Dr. Breeden was accepted into the U.S. Department of State’s Bureau of Education and Cultural Affairs’ (ECA) “U.S. Speaker Program,” where he will be extended the opportunity to support U.S. embassies and consulates around the world to engage with leaders, officials, and subject matter experts on topics of strategic importance to the U.S., including but not limited to social entrepreneurship and the power of equitable venture investment in diverse founders. Lastly, he is also a proud member of Kappa Alpha Psi Fraternity, Inc., ForbesBLK (a global community of Black entrepreneurs and leaders driving systematic change in business, culture, and society), and BLCK VC, a network committed to equipping Black investors with the resources needed to push for greater inclusivity in the venture capital industry.

THE FUND IS NOW ACCEPTING SUBSCRIPTION INQUIRIES:

Fuze Venture Growth Fund I is currently in its subscription phase, and while capital deployment will begin once the fund is fully subscribed, accredited investors are welcome to engage. Entrepreneurs and investors alike are invited to join the Fuze Fund network and contribute to an initiative that’s driving diversity and innovation within the venture capital landscape. “We’re building more than just a fund. We’re building a community that ensures talented, underrepresented founders have a real shot at success. This fund is about changing the status quo, and we invite like-minded investors and entrepreneurs to join us on this transformative journey!”

ABOUT FUZE FUND:

Fuze Fund is a venture management platform dedicated to empowering underrepresented founders by providing capital, strategic guidance, and resources. For more information, visit www.fuze.fund.

Media Contact

Dr. T.J. Breeden, Fuze Fund, LLC, 1 (919)627-7627, info@fuze.fund, www.fuze.fund

View original content to download multimedia:https://www.prweb.com/releases/fuze-fund-launches-30m-venture-capital-fund-to-empower-underrepresented-entrepreneurs-302268757.html

SOURCE Fuze Fund, LLC